Summit Therapeutics D
D
SMMT
19.770
USD
-0.37
(-1.84%)
مغلق
حجم التداول
93,768
الربح لكل سهم
-0
العائد الربحي
-
P/E
-58
حجم السوق
14,682,505,317
الأخبار المقالات
العنوان: Summit Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.